BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26875134)

  • 1. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
    Saneeymehri SS; Markey KR; Mahipal A
    J Oncol Pharm Pract; 2016 Jun; 22(3):552-5. PubMed ID: 25852107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
    Shah NR; Shah A; Rather A
    J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible.
    Güvenç TS; Celiker E; Ozcan KS; Ilhan E; Eren M
    Chin Med J (Engl); 2012 Sep; 125(18):3349-51. PubMed ID: 22964337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
    Scott PA; Ferchow L; Hobson A; Curzen NP
    Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
    Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
    World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer.
    Dzaye O; Cleator S; Nihoyannopoulos P
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-fluorouracil-induced coronary vasospasm.
    Shoemaker LK; Arora U; Rocha Lima CM
    Cancer Control; 2004; 11(1):46-9. PubMed ID: 14749623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine.
    Lampropoulos S; Roditis P; Koulouris E; Zafiris A; Tzimou M; Kyratlidis K; Pavlidis K; Godwin SA; Kosmas C
    Anticancer Drugs; 2017 Aug; 28(7):801-807. PubMed ID: 28489615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.
    Mizuno Y; Hokamura Y; Kimura T; Kimura Y; Kaikita K; Yasue H
    Jpn Circ J; 1995 May; 59(5):303-7. PubMed ID: 7596036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine-associated coronary vasospasm: a case report.
    Papadopoulos CA; Wilson H
    Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
    Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
    Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoropyrimidine-Associated Cardiotoxicity: A Retrospective Case-Control Study.
    Raber I; Warack S; Kanduri J; Pribish A; Godishala A; Abovich A; Orbite A; Dommaraju S; Frazer M; Peters ML; Asnani A
    Oncologist; 2020 Mar; 25(3):e606-e609. PubMed ID: 32162823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-induced chest pain relieved by diltiazem.
    Ambrosy AP; Kunz PL; Fisher GA; Witteles RM
    Am J Cardiol; 2012 Dec; 110(11):1623-6. PubMed ID: 22939579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
    Saif MW; Garcon MC; Rodriguez G; Rodriguez T
    In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.
    Stewart T; Pavlakis N; Ward M
    Intern Med J; 2010 Apr; 40(4):303-7. PubMed ID: 20529041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis Vindicated: A Case of Chest Pain Due to Capecitabine-Induced Coronary Artery Spasm.
    Thomesen K; Kisling A; Conte L; Park D; Gallagher R
    Am J Case Rep; 2024 Jan; 25():e941759. PubMed ID: 38217283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.